Pfizer COVID antiviral: Dozens of companies to start making pill

Nearly three dozen companies in Asia, the Caribbean, the Middle East and Eastern Europe will soon start making either generic versions of Pfizer's coronavirus pill or the raw ingredients. This deal will make the antiviral nirmatrelvir, or Paxlovoid, available to more than half of the world's population.

Everyday life can be a struggle for kids with COVID

More than 12.7 million children in the U.S. alone have tested positive for the coronavirus since the pandemic began. Some youngsters suffer unexplained symptoms long after the virus is gone — what's often called long COVID. Others get reinfected. Some seem to recover fine, only to be struck later by a mysterious condition that causes severe organ inflammation.

How has the COVID-19 pandemic changed after two years?

Two years after the pandemic began, more countries are shifting toward a return to normal and learning to live with the virus. Safe and effective vaccines have been developed and experts know a lot more about how to keep the coronavirus under control since it emerged in late 2019.